ANI Pharmaceuticals (ANIP) vs Phibro Animal Health (PAHC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Phibro Animal Health (PAHC) has outperformed ANI Pharmaceuticals (ANIP) over the past year, gaining 0.8% versus a loss of 21.5%. Over five years, ANIP leads with a +86.8% price change compared with +71.6% for PAHC. ANI Pharmaceuticals is the larger company by market cap ($1.70 billion vs $1.56 billion), about 1.1 times the size.
On valuation, ANI Pharmaceuticals trades at a lower forward P/E (7.3x vs 10.0x for Phibro Animal Health). Phibro Animal Health pays a dividend yielding 1.25%, while ANI Pharmaceuticals does not currently pay one. ANI Pharmaceuticals converts more of its revenue into profit, with a net margin of 8.9% versus 6.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ANIP | PAHC |
|---|---|---|
| Share price | $73.89 | $38.30 |
| Market cap | $1.70B | $1.56B |
| 1-day change | +2.65% | +2.41% |
| YTD return | -8.82% | +0.11% |
| 1-year return | -21.46% | +0.78% |
| 5-year return | +86.77% | +71.56% |
| P/E ratio (TTM) | 15.99 | 15.76 |
| Forward P/E | 7.27 | 9.97 |
| EPS (TTM) | $4.62 | $2.43 |
| Dividend yield | 0.00% | 1.25% |
| Annual dividend | $0.00 | $0.48 |
| Revenue (latest FY) | $883.37M | $1.52B |
| Revenue growth (YoY) | +43.78% | +17.12% |
| Net income (latest FY) | $78.34M | $99.72M |
| Gross margin | 61.36% | 33.76% |
| Operating margin | 12.58% | 12.81% |
| Net margin | 8.87% | 6.57% |
| 52-week high | $97.00 | $60.08 |
| 52-week low | $69.58 | $28.25 |
| Distance from 52-week high | -23.82% | -36.25% |
| Analyst consensus | buy | hold |
| Avg. price target upside | +43.16% | +14.88% |
| Average volume | 374.47K | 236.19K |
| Shares outstanding | 22.96M | 21.11M |
| Employees | 970 | 2,605 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PAHC has outperformed ANIP by 22.2 percentage points over the past year.
- Phibro Animal Health offers a meaningfully higher dividend yield (1.25% vs 0.00%).
- ANI Pharmaceuticals grew revenue faster in its latest fiscal year (+43.78% vs +17.12%).
About ANI Pharmaceuticals
ANIP stock →ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products.
Health Care · Biotechnology: Pharmaceutical Preparations · 970 employees
About Phibro Animal Health
PAHC stock →Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products.
Health Care · Biotechnology: Pharmaceutical Preparations · 2,605 employees
ANIP vs PAHC FAQ
Which is bigger, ANI Pharmaceuticals or Phibro Animal Health?
ANI Pharmaceuticals (ANIP) is larger, with a market capitalization of $1.70B compared with $1.56B for Phibro Animal Health (PAHC).
Which stock has performed better over the past year, ANIP or PAHC?
PAHC returned +0.78% over the past 12 months, compared with -21.46% for ANIP (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, ANIP or PAHC?
PAHC has the lower trailing P/E at 15.8, versus 16.0 for ANIP. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, ANI Pharmaceuticals or Phibro Animal Health?
Phibro Animal Health pays a dividend yielding 1.25%, while ANI Pharmaceuticals does not currently pay a regular dividend.
Are ANI Pharmaceuticals and Phibro Animal Health in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.